On December 20, PHARMARON (03759.HK) spent 13.7375 million Hong Kong dollars to repurchase 1 million shares.

On December 20, Gelonghui reported that PHARMARON (03759.HK) announced the repurchase of 1 million shares at a cost of 13.7375 million Hong Kong dollars on December 20, 2024, with a repurchase price ranging from 13.58 to 13.94 Hong Kong dollars per share.

Gelonghui FinanceDec 20 17:45

Share repurchase collection on December 19 | TENCENT, AIA and others have repurchased shares, among which TENCENT spent 0.703 billion HKD.

According to the documents disclosed by HKEX on December 20, TENCENT (00700.HK), AIA (01299.HK), and others have repurchased shares. ① TENCENT (00700.HK) repurchased 1.72 million ordinary shares on December 19, involving an amount of 0.703 billion HKD, with the repurchase price ranging from 421.8 HKD to 401.4 HKD per share. Since the repurchase authorization resolution, the cumulative number of repurchased securities is 0.221 billion shares, accounting for 2.347% of the number of shares issued when the ordinary resolution was passed. ② AIA (01299.HK)

Futu NewsDec 20 09:00

The current cycle of Traditional Chinese Medicine materials is entering a downturn phase, and pharmaceutical companies may face a cost "turning point."

In the second half of 2024, the prices of Traditional Chinese Medicine materials are expected to decline overall; the semi-annual and third quarter reports of this year show that the gross margin of some Chinese Patent Medicine listed companies has significantly decreased, indicating a notable impact of the fluctuation in Traditional Chinese Medicine material prices on costs. However, with the retreat in Traditional Chinese Medicine material prices, production costs for companies will also decrease.

cls.cnDec 19 22:27

On December 19, PHARMARON (03759.HK) spent 5.4567 million Hong Kong dollars to repurchase 0.4 million shares.

On December 19, Gelonghui announced that PHARMARON (03759.HK) spent HKD 5.4567 million to repurchase 0.4 million shares on December 19, 2024, with a repurchase price of HKD 13.48-13.8 per share.

Gelonghui FinanceDec 19 17:12

Pharmaron Beijing Co., Ltd. Holds Successful Shareholder Meetings

TipRanksDec 18 19:44

On December 18, PHARMARON (03759.HK) spent 5.5632 million HKD to repurchase 0.4 million shares.

Glory Financial reported on December 18 that PHARMARON (03759.HK) announced it will spend 5.5632 million Hong Kong dollars to repurchase 0.4 million shares on December 18, 2024, with a buyback price of 13.76-14 Hong Kong dollars per share.

Gelonghui FinanceDec 18 17:26